Kontakt 2012, 14(1):68-84 | DOI: 10.32725/kont.2012.009

Anxiolytics of natural origin I. Originally occurring plants and plants cultivated in the Czech RepublicBiomedicine - Review

Zdeňka Navrátilová
Přírodovědecká fakulta Univerzity Karlovy v Praze, katedra botaniky

Anxious disorders belong to most frequently encountered mental disorders in general, since up to 25% of the population suffers by a clinically important anxious disorder at least once in a lifetime. Anxiolytics and antidepressants are particularly used to treat anxiety. and insomnia is treated with sedatives and hypnotics. There are a number of products for the treatment of the anxiety, but in benzodiazepine-group anxiolytics, there is a risk of the tolerance and addiction development. Thus, a great attention is being paid to the investigation of new medicines without these side effects. There are a number of plants, which have been traditionally used for the treatment of anxiety and insomnia and these effects are frequently supported by modern trials. Herbaceous products are frequently used even at the time being, particularly for the treatment of mild problems. Tea mixtures, tinctures, food supplements and registered medicinal products containing extracts from plants are used. Further research of effects of these plants and their components can offer new pharmaceuticals.
In the article presented here, there is an outline of main plants used in the treatment of anxiety and insomnia. The first part of the article is aimed at our original plants and plants cultivated in our country (Cannabis sativa, Coriandrum sativum, Crocus sativus, Eschscholzia californica, Ginkgo biloba, Humulus lupulus, Hypericum perforatum, Lavandula angustifolia, Magnolia officinalis and M. obovata, Matricaria recutita, Melissa officinalis, Rhodiola rosea, Scutellaria spp., Tilia americana and Valeriana officinalis), and the second part deals with exotic plants (Atractylodes macrocephala, Bacopa monnieri, Centella asiatica, Citrus spp., Clitoria ternatea, Echium amoenum, Erythrina mulungu, Morinda citrifolia, Myristica fragrans, Ocimum sanctum, Panax ginseng and P. quinquefolius, Passiflora incarnata, Piper methysticum, Sceletium tortuosum, Withania somnifera, Zingiber officinale and Ziziphus jujuba).

Keywords: anxiety disorders; anxiolytics; herbal remedy; traditional medicine

Received: December 17, 2011; Accepted: February 16, 2012; Published: March 16, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Navrátilová Z. Anxiolytics of natural origin I. Originally occurring plants and plants cultivated in the Czech Republic. Kontakt. 2012;14(1):68-84. doi: 10.32725/kont.2012.009.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Aguirre-Hernández E, Martínez AL, Gonzáles-Trujano ME, Moreno J, Vibrans H, Soto-Hernández M (2007). Pharmacological evaluation of the anxiolytic and sedative effects of Tilia americana L. var. mexicana in mice. J Ethnopharmacol. 109/1: 140-145. Go to original source... Go to PubMed...
    2. Akhondzadeh S, Kashani L, Fotouhi A, Jarvandi S, Mobaseri M, Moin M, Khani M, Jamshidi AH, Baghalian K, Taghizadeh M (2003). Comparison of Lavandula angustifolia Mill. tincture and imipramine in the treatment of mild to moderate depression: a double-blind, randomized trial. Prog Neuropsychopharmacol Biol Psychiatry. 27/1: 123-127. Go to original source... Go to PubMed...
    3. Akhondzadeh S, Tahmacebi-Pour N, Noorbala A-A, Amini H, Fallah-Pour H, Jamshidi A-H, Khani M (2005). Crocus sativus L. in the treatment of mild to moderate depression: a double blind, randomized and placebo-controlled trial. Phytother Res. 19/2: 148-151. Go to original source... Go to PubMed...
    4. Amar MB (2006). Cannabinoids in medicine: A review of their therapeutic potential. J Ethnopharmacol. 105/1-2: 1-25. Go to original source... Go to PubMed...
    5. Amsterdam JD, Li Y, Soeller I, Rockwell K, Mao JJ, Shults J (2009). A randomized, double-blind, placebo-controlled trial of oral Matricaria recutita (chamomile) extract therapy for generalized anxiety disorder. J Clin Psychopharmacol. 29/4: 378-382. Go to original source... Go to PubMed...
    6. Andreatini R, Sartori VA, Seabra MLV, Leite JR (2002). Effect of valepotriates (valerian extract) in generalized anxiety disorder: a randomized placebo-controlled pilot study. Phytother Res. 16/7: 650-654. Go to original source... Go to PubMed...
    7. Atanassova-Shopova S, Roussinov KS (1970). On certain central neurotropic effects of lavender essential oil. [Article in Bulgarian] Izv Inst Fiziol (Sofia). 13: 69-77.
    8. Awad R, Arnason JT, Trudeau V, Bergeron C, Budzinski JW, Foster BC, Merali Z (2003). Phytochemical and biological analysis of Skullcap (Scutellaria lateriflora L.): A medicinal plant with anxiolytic properties. Phytomedicine. 10/8: 640-649. Go to original source... Go to PubMed...
    9. Awad R, Muhammad A, Durst T, Trudeau VL, Arnason JT (2009). Bioassay-guided fractionation of lemon balm (Melissa officinalis L.) using an in vitro measure of GABA transaminase activity. Phytother Res. 23/8: 1075-1081. Go to original source... Go to PubMed...
    10. Barnes J, Anderson LA, Phillipson JD (2007). Herbal Medicines 3rd ed. Pharmaceutical Press London, Chicago, 710 p.
    11. Benke D, Barberis A, Kopp S, Altmann K-H, Schubiger M, Vogt KE, Rudolph U, Möhler H (2009). GABAA receptors as in vivo substrate for the anxiolytic action of valerenic acid, a major constituent of valerian root extracts. Neuropharmacology. 56/1: 174-181. Go to original source... Go to PubMed...
    12. Bouček J, Pidrman V (2005). Psychofarmaka v medicíně. Praha: Grada, 304 s.
    13. Braden R, Reichow S, Halm MA (2009). The use of the essential oil lavandin to reduce preoperative anxiety in surgical patients. J Perianesth Nurs. 24/6: 348-355. Go to original source... Go to PubMed...
    14. Bradley BF, Starkey NJ, Brown SL, Lea RW (2007). Anxiolytic effects of Lavandula angustifolia odour on the Mongolian gerbil elevated plus maze. J Ethnopharmacol. 111/3: 517-525. Go to original source... Go to PubMed...
    15. Bruneton J (1999). Pharmacognosy. Phytochemistry. Medicinal Plants. 2nd ed. Intercept Ltd, Londres, Paris, New York, 1119 p.
    16. Bystritsky A, Kerwin L, Feusner JD (2008). A pilot study of Rhodiola rosea (Rhodax) for generalized anxiety disorder (GAD). J Altern Complement Med. 14/2: 175-180. Go to original source... Go to PubMed...
    17. de Carvalho RS, Duarte FS, de Lima TC (2011). Involvement of GABAergic non-benzodiazepine sites in the anxiolytic-like and sedative effects of the flavonoid baicalein in mice. Behav Brain Res. 221/1: 75-82. Go to original source... Go to PubMed...
    18. Devane WA, Hanuš L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R (1992). Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 258/5090: 1946-9. Go to original source... Go to PubMed...
    19. Di Marzo V, De Petrocellis L (2006). Plant, synthetic, and endogenous cannabinoids in medicine. Annu. Rev. Med. 57: 553-574 Go to original source... Go to PubMed...
    20. Di Renzo G (2000). Ginkgo biloba and the central nervous system. Fitoterapia. 71/Suppl 1: S43-S47. Go to original source... Go to PubMed...
    21. Emamghoreish M, Khasaki M, Aazam MF (2005). Coriandrum sativum: evaluation of its anxiolytic effect in the elevated plus-maze. J Ethnopharmacol. 96/3: 365-370. Go to original source... Go to PubMed...
    22. Ernst E (2006). Herbal remedies for anxiety - a systematic review of controlled clinical trials. Phytomedicine. 13/3: 205-208. Go to original source... Go to PubMed...
    23. ESCOP (European Scientific Cooperative on Phytotherapy) (2003). The ESCOP Monographs 2. ed. 556 p.
    24. ESCOP (European Scientific Cooperative on Phytotherapy) (2009). The ESCOP Monographs 2. ed. Supplement 2009. 306 p.
    25. Evans WC (2001). Trease & Evans' Pharmacognosy. 15th ed. Bailliere Tindall. 585 p.
    26. Fišar Z (2006a). Fytokanabinoidy. Chem Listy. 100/4: 233-242.
    27. Fišar Z (2006b). Endokanabinoidy. Chem Listy. 100/5: 314-322.
    28. Guillemain J, Rousseau A, Delaveau P (1989). Effets neurodépresseurs de l'huile essentielle de Lavandula angustifolia Mill. Ann Pharmaceutiques Françaises. 47/6: 337-343.
    29. Haller J, Varga B, Ledent C, Freund TF (2004). CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1-specific agents. Behav Pharmacol. 15/4: 299-304. Go to original source... Go to PubMed...
    30. Han H, Jung JK, Han SB, Nam SY, Oh KW, Hong JT (2011). Anxiolytic-like effects of 4-O-methylhonokiol isolated from Magnolia officinalis through enhancement of GABAergic transmission and chloride influx. J Med Food. 14/7-8: 724-731. Go to original source... Go to PubMed...
    31. Hattesohl M, Feistel B, Sievers H, Lehnfeld R, Hegger M, Winterhoff H (2008). Extracts of Valeriana officinalis L. s.l. show anxiolytic and antidepressant effects but neither sedative nor myorelaxant properties. Phytomedicine. 15/1-2: 2-15. Go to original source... Go to PubMed...
    32. Herrera-Ruiz M, Román-Ramos R, Zamilpa A (2008). Flavonoids from Tilia americana with anxiolytic activity in plus-maze test. J Ethnopharmacol. 118/2: 312-317. Go to original source... Go to PubMed...
    33. Hosseinzadeh H, Noraei NB (2009). Anxiolytic and hypnotic effect of Crocus sativus aqueous extract and its constituents, crocin and safranal, in mice. Phytother Res. 23/6: 768-774. Go to original source... Go to PubMed...
    34. Hui KM, Huen MS, Wang HY, Zheng H, Sigel E, Baur R, Ren H, Li ZW, Wong JT, Xue H (2002). Anxiolytic effect of wogonin, a benzodiazepine receptor ligand isolated from Scutellaria baicalensis Georgi. Biochem Pharmacol. 64/9: 1415-1424. Go to original source... Go to PubMed...
    35. Chadwick LR, Pauli GF, Farnsworth NR (2006). The pharmacognosy of Humulus lupulus L. (hops) with an emphasis on estrogenic properties. Phytomedicine. 13/1-2: 119-131. Go to original source... Go to PubMed...
    36. Chen QG, Zeng YS, Qu ZQ, Tang JY, Quin YJ, Chung P, Wong R, Hägg U (2009). The effects of Rhodiola rosea extract on 5-HT level, cell proliferation and quantity of neurons at cerebral hippocampus of depressive rats. Phytomedicine. 16/9: 830-838. Go to original source... Go to PubMed...
    37. Ibarra A, Feuillere N, Roller M, Lesburgere E, Beracochea D (2010). Effects of chronic administration of Melissa officinalis L. extract on anxiety-like reactivity and on circadian and exploratory activities in mice. Phytomedicine. 17/6: 397-403. Go to original source... Go to PubMed...
    38. Iversen L (2003). Cannabis and the brain. Brain. 126/6: 1252-1270. Go to original source... Go to PubMed...
    39. Izzo A, Ernst E (2001). Interactions between herbal medicines and prescribed drugs - A systematic review. Drugs. 61/13: 2163-2175. Go to original source... Go to PubMed...
    40. Kennedy DO, Little W, Haskell CF, Scholey AB (2006). Anxiolytic effects of a combination of Melissa officinalis and Valeriana officinalis during laboratory induced stress. Phytother Res. 20/2: 96-102. Go to original source... Go to PubMed...
    41. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen HU, Kendler KS (1994). Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Arch Gen Psychiatry. 51/1: 8-19. Go to original source... Go to PubMed...
    42. Kobak KA, Taylor LV, Bystritsky A, Kohlenberg CJ, Greist JH, Tucker P, Warner G, Futterer R, Vapnik T (2005a). St John's wort versus placebo in obsessive-compulsive disorder: results from a double-blind study. Int Clin Psychopharmacol. 20/6: 299-304. Go to original source... Go to PubMed...
    43. Kobak KA, Taylor LV, Warner G, Futterer R (2005b). St. John's wort versus placebo in social phobia: results from a placebo-controlled pilot study. J Clin Psychopharmacol. 25/1: 51-58. Go to original source... Go to PubMed...
    44. Kolektiv autorů (2009). Český lékopis 2009. Praha: Grada.
    45. Korbelář J, Endris Z, Krejča J (1985). Naše rostliny v lékařství 6. vyd. Praha: Avicenum, 501 s.
    46. Kritsidima M, Newton T, Asimakopoulou K (2010). The effects of lavender scent on dental patient anxiety levels: a cluster randomised-controlled trial. Community Dent Oral Epidemiol. 38/1: 83-87. Go to original source... Go to PubMed...
    47. Kubát K, Hrouda L, Chrtek J, Jr., Kaplan Z, Kirschner J, Štěpánek J (eds.) (2002). Klíč ke květeně České republiky. Praha: Academia, 928 s.
    48. Kuribara H, Stavinoha WB, Maruyama Y (1999). Honokiol, a putative anxiolytic agent extracted from magnolia bark, has no diazepam-like side-effects in mice. J Pharm Pharmacol. 51/1: 97-103. Go to original source...
    49. Linde K, Mulrow CD, Berner M, Egger M (2005). St John's wort for depression. Cochrane Database Syst Rev. 2: CD000448. Go to original source...
    50. Linde K, Berner MM, Kriston L (2008). St John's wort for major depression. Cochrane Database Syst Rev. 4: CD000448. Go to original source...
    51. Mahendra P, Bisht S (2011). Anti-anxiety activity of Coriandrum sativum assessed using different experimental anxiety models. Indian J Pharmacol. 43/5: 574-577. Go to original source... Go to PubMed...
    52. Martínez AL, González-Trujano ME, Aguirre-Hernández E, Moreno J, Soto-Hernández M, López-Muñoz FJ (2009). Antinociceptive activity of Tilia americana var. mexicana inflorescences and quercetin in the formalin test and in an arthritic pain model in rats. Neuropharmacology. 56/2: 564-571. Go to original source... Go to PubMed...
    53. Mattioli L, Perfumi M (2011a). Evaluation of Rhodiola rosea L. extract on affective and physical signs of nicotine withdrawal in mice. J Psychopharmacol. 25/3: 402-410. Go to original source... Go to PubMed...
    54. Mattioli L, Perfumi M (2011b). Effects of a Rhodiola rosea L. extract on acquisition and expression of morphine tolerance and dependence in mice. J Psychopharmacol. 25/3: 411-420. Go to original source... Go to PubMed...
    55. Moradkhani H, Sargsyan E, Bibak H, Naseri B, Sadat-Hosseini M, Fayazi-Barjin A, Meftahizade H (2010). Melissa officinalis L., a valuable medicine plant: A review. JMPR. 4/25: 2753-2759.
    56. Müller T, Mannel M, Murck H, Rahlfs VW (2004). Treatment of somatoform disorders with St. John's wort: a randomized, double-blind and placebo-controlled trial. Psychosom Med. 66/4: 538-547. Go to original source... Go to PubMed...
    57. Murphy K, Kubin ZJ, Shepherd JN, Ettinger RH (2010). Valeriana officinalis root extracts have potent anxiolytic effects in laboratory rats. Phytomedicine. 17/8-9: 674-678. Go to original source... Go to PubMed...
    58. Musty RE (1984). Possible anxiolytic effects of cannabidiol. In: Agurell S, Dewey W, Willette R (eds.). The Cannabinoids. Academic Press, New York. p. 829-844. Go to original source...
    59. Musty RE (2005). Cannabinoids and anxiety. In: Mechoulam R (ed.). Cannabinoids as Therapeutics. Birkhäuser Verlag Switzerland. p. 141-147. Go to original source...
    60. Panossian A, Wikman G, Sarris J (2010). Rosenroot (Rhodiola rosea): Traditional use, chemical composition, pharmacology and clinical efficacy. Phytomedicine. 17/7: 481-493. Go to original source... Go to PubMed...
    61. Park HG, Yoon SY, Choi JY, Lee GS, Choi JH, Shin CY, Son KH, Lee YS, Kim WK, Ryu JH, Ko KH, Cheong JH (2007). Anticonvulsant effect of wogonin isolated from Scutellaria baicalensis. Eur J Pharmacol. 574/2-3: 112-119. Go to original source... Go to PubMed...
    62. Patočka J (2003). Standardizovaný extrakt třezalky tečkované: nové rostlinné antidepresivum. VZL. 72/3: 114-118.
    63. Patočka J, Strunecká A (2001). Ginkgo biloba L. (jinan dvoulaločný) - symbol životní síly. Psychiatrie. 5/4: 261-264.
    64. Patočka J, Jakl J (2010). Biomedically relevant chemical constituents of Valeriana officinalis. J Appl Biomed. 8/1: 11-18. Go to original source...
    65. Patočka J, Strunecká A, Jakl J (2002). Magnolie mohou být nejen krásné, ale i užitečné. Psychiatrie. 6/4: 231-235.
    66. Peč J, Dušek J (2009). Konopí, konopná droga a související léčivé přípravky. Prakt Lékáren. 5/4: 189-193.
    67. Pertwee RG (2005). The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids. AAPSJ. 7/3: 625-654. Go to original source... Go to PubMed...
    68. Polívka F (1996). Užitkové a pamětihodné rostliny cizích zemí. Reprint z roku 1908, Volvox globator Praha, 646 s.
    69. Praško J (2001). Úzkostné poruchy. Postgrad Med. 3/12: 238-248.
    70. Praško J (2004). Úzkostné poruchy. Interní Med. 6/10: 500-503.
    71. Qiang L-Q, Wang C-P, Wang F-M, Pan Y, Yi L-T, Zhang X, Kong L-D (2009). Combined administration of the mixture of honokiol and magnolol and ginger oil evokes antidepressant-like synergism. Arch Pharm Res. 32/9: 1281-1292. Go to original source... Go to PubMed...
    72. Rätsch C (2005). The Encyclopedia of Psychoactive Plants: Ethnopharmacology and Its Applications. Park Street Press Rochester, Vermont, 944 p.
    73. Rolland A, Fleurentin J, Lanhers MC, Younos C, Misslin R, Mortier F, Pelt JM (1991). Behavioural effects of the American traditional plant Eschscholzia californica: sedative and anxiolytic properties. Planta Med. 57/3: 212-216. Go to original source... Go to PubMed...
    74. Rolland A, Fleurentin J, Lanhers MC, Misslin R, Mortier F (2001). Neurophysiological effects of an extract of Eschscholzia californica Cham. (Papaveraceae). Phytother Res. 15/5: 377-381. Go to original source... Go to PubMed...
    75. Sarris J, Kavanagh DJ (2009). Kava and St. John's Wort: Current Evidence for Use in Mood and Anxiety Disorders. J Altern Complement Med. 15/8: 1-10. Go to original source... Go to PubMed...
    76. Sarris J, Panossian A, Schweitzer I, Stough C, Scholey A (2011). Herbal medicine for depression, anxiety and insomnia: A review of psychopharmacology and clinical evidence. Eur Neuropsychopharmacol. 21/12: 841-860. Go to original source... Go to PubMed...
    77. Seo JJ, Lee SH, Lee YS, Kwon BM, Ma Y, Hwang BY, Hong JT, Oh KW (2007). Anxiolytic-like effects of obovatol isolated from Magnolia obovata: involvement of GABA/benzodiazepine receptors complex. Prog Neuropsychopharmacol Biol Psych. 31/7: 1363-1369. Go to original source... Go to PubMed...
    78. Shaw D, Annett JM, Doherty B, Leslie JC (2007). Anxiolytic effects of lavender oil inhalation on open-field behaviour in rats. Phytomedicine. 14/9: 613-620. Go to original source... Go to PubMed...
    79. Shelton RC, Keller MB, Gelenberg A, Dunner DL, Hirschfeld R, Thase ME, Russell J, Lydiard RB, Crits-Cristoph P, Gallop R, Todd L, Hellerstein D et al. (2001). Effectiveness of St John's wort in major depression: a randomized controlled trial. JAMA. 285/15: 1978-1986. Go to original source... Go to PubMed...
    80. Schiller H, Forster A, Vonhoff C, Hegger M, Biller A, Winterhoff H (2006). Sedating effects of Humulus lupulus L. extracts. Phytomedicine. 13/8: 535-541. Go to original source... Go to PubMed...
    81. Schmidt M, Betti G, Hensel A (2007). Saffron in phytotherapy: Pharmacology and clinical uses. Wien Med Wochenschr. 157/13-14: 315-319. Go to original source... Go to PubMed...
    82. Soulimani R, Fleurentin J, Mortier F, Misslin R, Derrieu G, Pelt JM (1991). Neurotropic action of the hydroalcoholic extract of Melissa officinalis in the mouse. Planta Med. 57/2: 105-109. Go to original source... Go to PubMed...
    83. Švestka J (2002) Třezalka tečkovaná (Hypericum perforatum Linn.) - rostlinné antidepresivum. Psychiatrie. 6/2: 109-120.
    84. Tomko J, Kresánek J, Hubík J, Suchý V, Felklová M, Sikyta B, Libický A (1999). Farmakognózia. 2. vyd. Martin: Osveta, 358 s.
    85. van Diermen D, Marston A, Bravo J, Reist M, Carrupt P-A, Hostettmann K (2009). Monoamine oxidase inhibition by Rhodiola rosea roots. J Ethnopharmacol. 122/2: 397-401. Go to original source... Go to PubMed...
    86. van Wyk B-E, Wink M (2005). Medicinal plants of the world. Timber Press, Portland, Oregon, USA, 480 p.
    87. Volz HP, Murck H, Kasper S, Möller HJ (2002). St John's wort extract (LI 160) in somatoform disorders: results of a placebo-controlled trial. Psychopharmacology (Berl). 164/3: 294-300. Go to original source... Go to PubMed...
    88. Votava M, Agová V, Kršiak M (2005). Mechanismy účinku anxiolytik. Psychiatr prax. 6/3: 131-133.
    89. WHO (World Health Organisation) (2007). WHO Monographs on Selected Medicinal Plants 3. 376 p.
    90. Williamson EM (2003). Potter's Herbal Cyclopaedia. The autoritative reference work on plants with a known medicinal use. Saffron Walden, The C. W. Daniel Company Limited, 503 p.
    91. Williamson EM, Evans FJ (2000). Cannabinoids in Clinical Practice. Drugs. 60/6: 1303-1314. Go to original source... Go to PubMed...
    92. Wink M, van Wyk B-E (2008). Mind-altering and poisonous plants of the world. Timber Press, Portland, London, 464 p.
    93. Woelk H (2000). Comparison of St John's wort and imipramine for treating depression: randomised controlled trial. BMJ. 321/7260: 536-539. Go to original source... Go to PubMed...
    94. Woelk H, Schläfke S (2010). A multi-center, double-blind, randomised study of the Lavender oil preparation Silexan in comparison to Lorazepam for generalized anxiety disorder. Phytomedicine. 17/2: 94-99. Go to original source... Go to PubMed...
    95. Woelk H, Arnoldt KH, Kieser M, Hoerr H (2007). Ginkgo biloba special extract EGb 761((R)) in generalized anxiety disorder and adjustment disorder with anxious mood: a randomized, double-blind, placebo-controlled trial. J Psychiatr Res. 41/6: 472-480. Go to original source... Go to PubMed...
    96. Wolfson P, Hoffmann DL (2003). An investigation into the efficacy of Scutellaria lateriflora in healthy volunteers. Altern Ther Health Med. 9/2: 74-78.
    97. Yamada K, Mimaki Y, Sashida Y (1994). Anticonvulsive effects of inhaling lavander oil vapour. Biol Pharm Bull. 17/2: 359-360. Go to original source... Go to PubMed...
    98. Yi L-T, Xu Q, Li Y-Ch, Yang L, Kong LD (2009). Antidepressant-like synergism of extracts from magnolia bark and ginger rhizome alone and in combination in mice. Prog Neuropsychopharmacol Biol Psych. 33/4: 616-624. Go to original source... Go to PubMed...
    99. Zanoli P, Rivasi M, Zavatti M, Brusiani F, Baraldi M (2005). New insight in the neuropharmacological activity of Humulus lupulus L. J Ethnopharmacol. 102/1: 102-106. Go to original source... Go to PubMed...
    100. Zanoli P, Zavatti M, Rivasi M, Brusiani F, Losi G, Puia G, Avallone R, Baraldi M (2007). Evidence that the β-acids fraction of hops reduces central GABAergic neurotransmission. J Ethnopharmacol. 109/1: 87-92. Go to original source... Go to PubMed...

    Return to the content